We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+19.58%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$521M
AUM Growth
+$123M
Cap. Flow
+$74M
Cap. Flow %
14.2%
Top 10 Hldgs %
42.06%
Holding
160
New
57
Increased
37
Reduced
27
Closed
29

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$11.3M
2
AMZN icon
Amazon
AMZN
+$11.3M
3
EVA
Enviva Inc.
EVA
+$10.5M
4
MED icon
Medifast
MED
+$10.1M
5
CTLP
Cantaloupe
CTLP
+$8.31M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$13.6M
2
CVS icon
CVS Health
CVS
+$12.8M
3
RUN icon
Sunrun
RUN
+$11M
4
ADBE icon
Adobe
ADBE
+$10.1M
5
NOW icon
ServiceNow
NOW
+$8.57M

Sector Composition

Rank Sector Weight
1 Technology 26.67%
2 Industrials 16.23%
3 Healthcare 15.24%
4 Consumer Discretionary 7.69%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCI
151
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-250
Closed -$74K
HTGM
152
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
– –
-194
Closed -$89K
TLND
153
DELISTED
Talend S.A. American Depositary Shares
TLND
– –
-202,150
Closed -$7.5M
GWPH
154
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-3,000
Closed -$292K
IMMU
155
DELISTED
Immunomedics Inc
IMMU
– –
-285,000
Closed -$4.07M
PGNX
156
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-500,000
Closed -$2.1M
MLNX
157
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-5,000
Closed -$462K
CFRX
158
DELISTED
ContraFect Corporation
CFRX
– –
-19
Closed -$23K
PVTL
159
DELISTED
Pivotal Software, Inc.
PVTL
– –
-354,900
Closed -$5.8M
ULTI
160
DELISTED
Ultimate Software Group Inc
ULTI
– –
-4,000
Closed -$979K
3 4 5 6
7

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Ardsley Advisory Partners held 160 positions worth $521M, up 31% from $398M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $74M of net new capital in Q1 2019, opening 57 new positions and adding to 37 existing holdings. Its largest new stake was Medifast: 80,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Sunrun, an estimated $11M trimmed.

  • Ardsley Advisory Partners's largest Q1 2019 buy was Medifast: 80,000 shares worth $10.2M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q1 2019, an estimated $11.3M increase.
  • Ardsley Advisory Partners's biggest Q1 2019 reduction was Sunrun, cutting an estimated $11M.
  • Ardsley Advisory Partners fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $13.6M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $521M portfolio in Q1 2019.
  • Ardsley Advisory Partners opened 57 new positions and closed 29 in Q1 2019.
  • Ardsley Advisory Partners's portfolio value rose 31% quarter-over-quarter to $521M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2019, filed 15 May 2019.